2022
DOI: 10.2147/dmso.s366403
|View full text |Cite
|
Sign up to set email alerts
|

The Role of PKM2 in Diabetic Microangiopathy

Abstract: Diabetic microangiopathy is among the most common complications affecting patients with diabetes, and includes both diabetic retinopathy (DR) and diabetic nephropathy (DKD). Diabetic microangiopathy remains a persistent threat to the health and quality of life of affected patients. Mechanistically, the severity of DR and DKD is tied to mitochondrial and glucose metabolism abnormalities, with the activation of the glycolytic enzyme pyruvate kinase M2 (PKM2) contributing to mitochondrial and glomerular dysfuncti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 57 publications
(61 reference statements)
0
1
0
Order By: Relevance
“…Pyruvate kinase M2 (PKM2) was more expressed in ASCs in DS compared to NS after 6 days of culture. This high expression can be correlated with the activation of the protective mechanism of ASCs against the DS microenvironment, as suggested by previous findings [ 79 ], since chronic inflammation related to diabetes tends to increase PKM2 levels [ 28 , 80 ]. Prolonged exposure of MSCs to oxidative stress upregulated SIRT1 expression, which activates the antioxidant protective factors that inhibit oxidative stress through AMPK activation [ 81 85 ].…”
Section: Discussionsupporting
confidence: 65%
“…Pyruvate kinase M2 (PKM2) was more expressed in ASCs in DS compared to NS after 6 days of culture. This high expression can be correlated with the activation of the protective mechanism of ASCs against the DS microenvironment, as suggested by previous findings [ 79 ], since chronic inflammation related to diabetes tends to increase PKM2 levels [ 28 , 80 ]. Prolonged exposure of MSCs to oxidative stress upregulated SIRT1 expression, which activates the antioxidant protective factors that inhibit oxidative stress through AMPK activation [ 81 85 ].…”
Section: Discussionsupporting
confidence: 65%
“…7 Glucose metabolic disorders can cause renal microangiopathy, leading to changes in glomerular filtration rate and renal blood flow. 8 Dyslipidemia promotes the subcutaneous deposition of lipids in blood vessels, leading to atherosclerosis and cardio-cerebrovascular diseases (ASCVD). 9 Long-term hyperglycemia and lipid disorders in T2DM could lead to ASCVD.…”
Section: Introductionmentioning
confidence: 99%